These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4204112)

  • 1. Studies on the treatment of experimental tuberculosis of the guinea pig with intermittent doses of isoniazid.
    Dickinson JM; Aber VR; Mitchison DA
    Tubercle; 1973 Sep; 54(3):211-24. PubMed ID: 4204112
    [No Abstract]   [Full Text] [Related]  

  • 2. Suitability of isoniazid and ethambutol for intermittent administration in the treatment of tuberculosis.
    Dickinson JM; Ellard GA; Mitchison DA
    Tubercle; 1968 Dec; 49(4):351-66. PubMed ID: 4975543
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of treatment of experimental tuberculosis in guinea pigs with isoniazid or with isoniazid combined with ethambutol, either in continous or in intermittent regimen].
    Sosnowski W; Rozniecki J; Tomaszkiewicz L; Bechcińska B; Cyperling I
    Gruzlica; 1970 Jan; 38(1):35-42. PubMed ID: 4984432
    [No Abstract]   [Full Text] [Related]  

  • 4. The suitability of new drugs for intermittent chemotherapy of tuberculosis. An experimental study.
    Dickinson JM
    Scand J Respir Dis Suppl; 1969; 69():91-8. PubMed ID: 4190279
    [No Abstract]   [Full Text] [Related]  

  • 5. Suitability of rifampicin for intermittent administration in the treatment of tuberculosis.
    Dickinson JM; Mitchison DA
    Tubercle; 1970 Mar; 51(1):82-94. PubMed ID: 4992976
    [No Abstract]   [Full Text] [Related]  

  • 6. Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.
    Pandey R; Sharma A; Zahoor A; Sharma S; Khuller GK; Prasad B
    J Antimicrob Chemother; 2003 Dec; 52(6):981-6. PubMed ID: 14613962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampicin in daily and intermittent treatment of experimental murine tuberculosis, with emphasis on late results.
    Grumbach F; Canetti G; Le Lirzin M
    Tubercle; 1969 Sep; 50(3):280-93. PubMed ID: 4981497
    [No Abstract]   [Full Text] [Related]  

  • 8. Intermittent rifampicin treatment in experimental tuberculosis.
    Algeorge G; Rudescu D; Petre A
    Arch Roum Pathol Exp Microbiol; 1973 Jun; 32(2):277-86. PubMed ID: 4584318
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of BCG-induced immunity on the bactericidal activity of isoniazid and rifampicin in experimental tuberculosis of the mouse and guinea-pig.
    Dhillon J; Mitchison DA
    Br J Exp Pathol; 1989 Feb; 70(1):103-10. PubMed ID: 2493801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of splenin on protein-synthetising function of the liver during treatment of experimental tuberculosis with large doses of isoniazid].
    Afrikanov II; Il'inykh AP
    Probl Tuberk; 1975; (7):74-8. PubMed ID: 1215372
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of high doses of isoniazid on biosynthesis of albunin in experimental tuberculosis.
    Africanov II
    East Afr Med J; 1979 Sep; 56(9):442-4. PubMed ID: 520263
    [No Abstract]   [Full Text] [Related]  

  • 12. Laboratory aspects of intermittent drug therapy.
    Mitchison DA; Dickinson JM
    Postgrad Med J; 1971 Nov; 47(553):737-41. PubMed ID: 4110538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis.
    Ahmad Z; Sharma S; Khuller GK
    Int J Antimicrob Agents; 2005 Oct; 26(4):298-303. PubMed ID: 16154726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the bactericidal activity in vivo of Rifampicin alone or associated with isoniazid].
    Nitti V; Ninni A; Natali P
    Arch Tisiol Mal Appar Respir; 1967 Oct; 22(10):859-70. PubMed ID: 4975183
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mycobacterium tuberculosis resistant drugs and their effect on guinea pigs inoculated with a mixture of sensitive and resistant M. tuberculosis].
    Belogurova VP
    Antibiotiki; 1971 May; 16(5):429-33. PubMed ID: 5002222
    [No Abstract]   [Full Text] [Related]  

  • 16. Bactericidal activity in vitro and in the guinea-pig of isoniazid, rifampicin and ethambutol.
    Dickinson JM; Mitchison DA
    Tubercle; 1976 Dec; 57(4):251-8. PubMed ID: 827836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of drug resistance of Mycobacterium tuberculosis on the therapeutic results of a drug to which sensitivity is retained(experimental data)].
    Belogurova VP; Ivanitskaia NN
    Antibiotiki; 1970 Feb; 15(2):154-7. PubMed ID: 4986204
    [No Abstract]   [Full Text] [Related]  

  • 18. Rifampicin in treatment of experimental tuberculosis in mice.
    Batten J
    Tubercle; 1969 Sep; 50(3):294-8. PubMed ID: 4981498
    [No Abstract]   [Full Text] [Related]  

  • 19. Rifampicin in experimental investigations on mice.
    Havel A; Adámek L; Simonová S
    Antibiot Chemother; 1970; 16():406-15. PubMed ID: 5002306
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of experimental tuberculosis in guinea pigs by continuous and intermittent regimen with special reference to ethambutol and rifampicin].
    Westfal I; Wiza J; Rudnicka M; Szymaczek-Meyer L
    Gruzlica; 1973 Jan; 41(1):1-8. PubMed ID: 4686876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.